Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
Neurosci Lett
    February 2026
  1. LI Z, Chen Z, Duan Z, Liu Y, et al
    Inhibition of Death-Associated Protein Kinase 1 ameliorates central and peripheral pathological changes in a mouse model of Parkinson's disease.
    Neurosci Lett. 2026;876:138546.
    >> Share

  2. LIU KT, Shui Y, Hong J, Xiao L, et al
    Hydrogen sulfide protects dopaminergic neurons via NLRP3 inflammasome inhibition in an MPTP mouse model of Parkinson's disease.
    Neurosci Lett. 2026 Feb 16:138547. doi: 10.1016/j.neulet.2026.138547.
    >> Share

    October 2025
  3. TOGAWA K, Matsumoto S, Deng L, Jin M, et al
    DOPAnization of alpha-synuclein exacerbates dopaminergic neurodegeneration in the substantia nigra.
    Neurosci Lett. 2025;865:138354.
    >> Share

  4. ZHGENTI N, Bakuradze E, Bibilashvili O, Koshoridze N, et al
    The role of BDNF/PI3K/AKT/Nrf2 signaling in nicotine's protective effects against MPTP-induced Parkinson's disease.
    Neurosci Lett. 2025;868:138412.
    >> Share

    August 2025
  5. WANG J, Hou J, Du M, Hou X, et al
    The mechanism of alpha-lipoic acid regulating dopaminergic neuronal damage in Parkinson's disease through the Nrf2/HMOX1 pathway.
    Neurosci Lett. 2025 Aug 3:138338. doi: 10.1016/j.neulet.2025.138338.
    >> Share

    July 2025
  6. DENG X, Zheng W, Xu H, Yang Y, et al
    Genetic analysis of TMEM230 variants in Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2025 Jul 29:138334. doi: 10.1016/j.neulet.2025.138334.
    >> Share

    May 2025
  7. SUGIYAMA K, Kuroiwa M, Shuto T, Hwang S, et al
    Subregion-specific suppression of dopamine D1 receptor expression prevents L-DOPA-induced dyskinesia in a mouse model of Parkinson's disease.
    Neurosci Lett. 2025 May 25:138273. doi: 10.1016/j.neulet.2025.138273.
    >> Share

  8. CORTES-ALTAMIRANO JL, Alfaro-Rodriguez A, Morraz-Varela A, Reyes-Long S, et al
    Changes in gene expression of D2 and D5 receptors in the thalamus and midbrain caused by a persistent painful stimulus in Parkinsonian rats.
    Neurosci Lett. 2025;859-861:138270.
    >> Share

    January 2025
  9. ORTEGA A, Laville A, Padilla-Orozco M, Parrado Y, et al
    Cortical beta oscillation in brain slices of hemi parkinsonian mice.
    Neurosci Lett. 2025;849:138128.
    >> Share

    October 2024
  10. ZHANG J, Dong M, Li Z, Li Z, et al
    Association of plasma neurofilament light chain and Lipoprotein-related phospholipase A2 with motor subtypes of Parkinson's disease.
    Neurosci Lett. 2024 Oct 16:138011. doi: 10.1016/j.neulet.2024.138011.
    >> Share

  11. VILLAMAR-FLORES CI, Rodriguez-Violante M, Abundes-Corona A, Alatriste-Booth V, et al
    Association between alterations in sleep spindles and cognitive decline in persons with Parkinson's disease.
    Neurosci Lett. 2024;842:138006.
    >> Share

    September 2024
  12. BAGWELL E, Shin M, Henkel N, Migliaccio D, et al
    1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated adult zebrafish as a model for Parkinson's Disease.
    Neurosci Lett. 2024;842:137991.
    >> Share

  13. JIANG M, Liu Y, Cao Y, Liu Y, et al
    Auxiliary diagnostic method of Parkinson's disease based on eye movement analysis in a virtual reality environment.
    Neurosci Lett. 2024 Sep 2:137956. doi: 10.1016/j.neulet.2024.137956.
    >> Share

    August 2024
  14. ZHANG W, Peng H, Yang D, Song G, et al
    Absence of motor impairments or pathological changes in TMEM230 knockout rats.
    Neurosci Lett. 2024;837:137921.
    >> Share

  15. FAN X, Tang Y, Wei Z, Shi F, et al
    Mitochondrial dysfunction and NDUFS3: Insights from a PINK1(B9) Drosophila model in Parkinson's disease pathogenesis.
    Neurosci Lett. 2024 Aug 3:137917. doi: 10.1016/j.neulet.2024.137917.
    >> Share

    July 2024
  16. CHEN J, Meng Q, Zhang Y, Liang Y, et al
    TrueTH: A user-friendly deep learning approach for robust dopaminergic neuron detection.
    Neurosci Lett. 2024;836:137871.
    >> Share

  17. HE Q, Zhou Y, Jin J, Tian Q, et al
    Association between NEK1 gene polymorphisms and the potential risk of sporadic Parkinson's disease in the Chinese Northern Han population: A case-control study.
    Neurosci Lett. 2024 Jul 18:137913. doi: 10.1016/j.neulet.2024.137913.
    >> Share

    June 2024
  18. MENG Q, Chen J, Liang Y, Zhang X, et al
    miR-142-3p alleviates neuronal apoptosis in Parkinson's disease via negatively regulating C9orf72.
    Neurosci Lett. 2024 Jun 26:137887. doi: 10.1016/j.neulet.2024.137887.
    >> Share

  19. MARANO M, Altavista MC, Cassetta E, Brusa L, et al
    The influence of sex on non-motor wearing-off in Parkinson's disease: A WORK-PD post-hoc study.
    Neurosci Lett. 2024 Jun 7:137850. doi: 10.1016/j.neulet.2024.137850.
    >> Share

    April 2024
  20. ZAMEER F, Jain P, Khan K, Pramod Kumar P, et al
    Unraveling the regulatory landscape of Parkinson disease: A molecular symphony of miRNAs, transcription factors, and high-risk genes.
    Neurosci Lett. 2024 Apr 25:137792. doi: 10.1016/j.neulet.2024.137792.
    >> Share

    March 2024
  21. LI Z, Liu J, Miao X, Ge S, et al
    Reorganization of structural brain networks in Parkinson's disease with postural instability/gait difficulty.
    Neurosci Lett. 2024 Mar 19:137736. doi: 10.1016/j.neulet.2024.137736.
    >> Share

    February 2024
  22. SARKAR S, Biswas A, Ansari S, Choudhury S, et al
    Association of dopamine receptor D3 polymorphism with Levodopa-induced Dyskinesia: A study on Parkinson's disease patients from India.
    Neurosci Lett. 2024;825:137706.
    >> Share

  23. ADLER CH, Serrano GE, Shill HA, Driver-Dunckley E, et al
    Symmetry of synuclein density in autopsied Parkinson's disease submandibular glands.
    Neurosci Lett. 2024;825:137702.
    >> Share

  24. TAKIZAWA S, Ohuchi K, Fujimaki A, Ito T, et al
    Effects of alpha7 nicotinic acetylcholine receptor agonist against alpha-synuclein-induced neurotoxicity.
    Neurosci Lett. 2024;823:137654.
    >> Share

  25. CAKIR M, Sacmaci H
    The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
    Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683.
    >> Share

    January 2024
  26. LIU H, Gong Z, Li Z, Ye T, et al
    Distribution, connection and function of ALDH1A1(+)/TH(+) neurons in substantia nigra pars reticulata of mouse.
    Neurosci Lett. 2024;818:137555.
    >> Share

    December 2023
  27. HU Q, Xu L, Liu X, Wang Y, et al
    Adenosine A(2A) receptor antagonist KW6002 protects against A53T mutant alpha-synuclein-induced brain damage and neuronal apoptosis in Parkinson's disease mice by restoring autophagic flux.
    Neurosci Lett. 2023 Dec 27:137610. doi: 10.1016/j.neulet.2023.137610.
    >> Share

  28. HUANG W, Wang Y, Huang W
    Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway.
    Neurosci Lett. 2023 Dec 22:137608. doi: 10.1016/j.neulet.2023.137608.
    >> Share

  29. RAJAN S, Sood A, Jain R, Kamatham PT, et al
    Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease.
    Neurosci Lett. 2023;820:137596.
    >> Share

    November 2023
  30. BILISTER EGILMEZ C, Azak Pazarlar B, Alper Erdogan M, Erbas O, et al
    Neuroprotective effect of dexpanthenol on rotenone-induced Parkinson's disease model in rats.
    Neurosci Lett. 2023 Nov 29:137575. doi: 10.1016/j.neulet.2023.137575.
    >> Share

  31. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    >> Share

  32. SINGH A, Panhelainen A, Voutilainen MH
    Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic midbrain culture for modeling dopamine neuron degeneration.
    Neurosci Lett. 2023;816:137510.
    >> Share

  33. PAN Y, Zong Q, Li G, Wu Z, et al
    Nuclear localization of alpha-synuclein induces anxiety-like behavior in mice by decreasing hippocampal neurogenesis and pathologically affecting amygdala circuits.
    Neurosci Lett. 2023;816:137490.
    >> Share

    October 2023
  34. MONAGHAN AS, Hooyman A, Dibble LE, Mehta SH, et al
    Cognitive Predictors of Responsiveness to Reactive Step Training in People with Parkinson's Disease at Fall-Risk.
    Neurosci Lett. 2023;817:137517.
    >> Share

    September 2023
  35. STATZ M, Schleuter F, Weber H, Kober M, et al
    Subthalamic nucleus deep brain stimulation does not alter growth factor expression in a rat model of stable dopaminergic deficiency.
    Neurosci Lett. 2023;814:137459.
    >> Share

  36. GENG X, Zou Y, Li J, Li S, et al
    Mesenchymal stem cell exosomes rich in miR-23b-3p affect the Wnt signaling pathway and promote neuronal autophagy to alleviate PD symptoms.
    Neurosci Lett. 2023;814:137437.
    >> Share

    August 2023
  37. HEO EJ, Lee Y, Hyung Seo M, Yeo S, et al
    Association between SGK1 and alpha-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model.
    Neurosci Lett. 2023 Aug 25:137464. doi: 10.1016/j.neulet.2023.137464.
    >> Share

  38. KAPLAN ALGIN A, Tomruk C, Gozde Aslan C, Saban Akkurt S, et al
    Effects of ozone treatment to the levels of neurodegeneration biomarkers after rotenone induced rat model of Parkinson's disease.
    Neurosci Lett. 2023;814:137448.
    >> Share

  39. HE P, Gao Y, Shi L, Li Y, et al
    Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers.
    Neurosci Lett. 2023 Aug 8:137435. doi: 10.1016/j.neulet.2023.137435.
    >> Share

  40. TAN Z, Lin Y, Zhou M, Guo W, et al
    Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic Parkinson's disease in Han population in Southern China.
    Neurosci Lett. 2023 Aug 4:137426. doi: 10.1016/j.neulet.2023.137426.
    >> Share

    July 2023
  41. TIAN Q, Sun X, Li C, Yang Y, et al
    CD33 polymorphisms and Parkinson's disease Parkinson's disease in northern Chinese Han population: A case-control study.
    Neurosci Lett. 2023;812:137400.
    >> Share

  42. LI Y, Li F, Liu X, Zu J, et al
    Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson's disease.
    Neurosci Lett. 2023 Jul 10:137394. doi: 10.1016/j.neulet.2023.137394.
    >> Share

  43. JIN H, Shen H, Liu C, Wang L, et al
    Decreased Serum BDNF Contributes to the Onset of REM Sleep Behavior Disorder in Parkinson's Disease Patients.
    Neurosci Lett. 2023 Jul 7:137380. doi: 10.1016/j.neulet.2023.137380.
    >> Share

    June 2023
  44. HWAN SHIN J, Ah Shin D, Young Lee C, Jin Chang H, et al
    Inability to suppress head rotation during the saccade test as a clinical biomarker for cognitive dysfunction in Parkinson's disease.
    Neurosci Lett. 2023 Jun 22:137356. doi: 10.1016/j.neulet.2023.137356.
    >> Share

  45. ZHENG Q, Ma P, Yang P, Zhai S, et al
    Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson's disease.
    Neurosci Lett. 2023 Jun 10:137346. doi: 10.1016/j.neulet.2023.137346.
    >> Share

    May 2023
  46. WANG X, Wei W, Bai Y, Shen Y, et al
    Intrinsic Brain Activity Alterations in Patients With Parkinson's disease.
    Neurosci Lett. 2023 May 15:137298. doi: 10.1016/j.neulet.2023.137298.
    >> Share

    April 2023
  47. ZHANG X, Zhong X, Wang L, Li H, et al
    Effects of soluble TREM2 on motor progression in Parkinson's disease.
    Neurosci Lett. 2023 Apr 25:137277. doi: 10.1016/j.neulet.2023.137277.
    >> Share

  48. ZHANG X, Li L, Qi L, Fu Y, et al
    Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.
    Neurosci Lett. 2023 Apr 13:137249. doi: 10.1016/j.neulet.2023.137249.
    >> Share

  49. SHIDA TKF, de Oliveira CEN, da Silva Fragoso de Campos D, Los Angeles E, et al
    Effect of freezing of gait and dopaminergic medication in the biomechanics of lower limbs in the gait of patients with Parkinson's disease compared to neurologically healthy.
    Neurosci Lett. 2023;806:137250.
    >> Share

  50. MURAKAMI Y, Nishijima H, Nakamura T, Furukawa T, et al
    Altered amantadine effects after repetitive treatment for l-dopa-induced involuntary movements in a rat model of Parkinson's disease.
    Neurosci Lett. 2023;806:137248.
    >> Share

  51. DONG L, Chang Q, Ma J, Liu C, et al
    Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Neurosci Lett. 2023;804:137219.
    >> Share

  52. MA C, Wei X, Wang F, Zhang T, et al
    Tumor necrosis factor alpha-induced protein 3 mediates inflammation and neuronal autophagy in Parkinson's disease via the NFkappaB and mTOR pathways.
    Neurosci Lett. 2023 Apr 3:137223. doi: 10.1016/j.neulet.2023.137223.
    >> Share

  53. MORRISON S, Reilly N, Schussler E, Kerr G, et al
    The effect of standing posture on amplitude and variability of postural tremor in Parkinson's disease.
    Neurosci Lett. 2023 Apr 3:137220. doi: 10.1016/j.neulet.2023.137220.
    >> Share

  54. YUAN M, Du N, Song Z
    Primary motor area-related injury of anterior central gyrus in Parkinson's disease with dyskinesia: a study based on MRS and Q-Space.
    Neurosci Lett. 2023 Apr 3:137224. doi: 10.1016/j.neulet.2023.137224.
    >> Share

    March 2023
  55. GOMEZ-MARTIN A, Fuentes JM, Jordan J, Galindo MF, et al
    Detection of rare Genetic Variations in the promoter regions of the ATG16L gene in Parkinson's patients.
    Neurosci Lett. 2023 Mar 21:137195. doi: 10.1016/j.neulet.2023.137195.
    >> Share

  56. LI W, Pan X, Li M, Ling L, et al
    Impact of age on the rotenone-induced sporadic Parkinson's disease model using Drosophila melanogaster.
    Neurosci Lett. 2023 Mar 13:137187. doi: 10.1016/j.neulet.2023.137187.
    >> Share

    February 2023
  57. OMAR AHMAD S, Longhurst J, Stiles D, Downard L, et al
    A meta-analysis of exercise intervention and the effect on Parkinson's Disease Symptoms.
    Neurosci Lett. 2023 Feb 28:137162. doi: 10.1016/j.neulet.2023.137162.
    >> Share

  58. CARNEY AE, Clarke C, Pratt WE
    Administration of neuropeptide Y into the rat nucleus accumbens shell, but not core, attenuates the motivational impairment from systemic dopamine receptor antagonism by alpha-flupenthixol.
    Neurosci Lett. 2023;797:137069.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016